A detailed history of High Vista Strategies LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 21,161 shares of KURA stock, worth $153,628. This represents 0.16% of its overall portfolio holdings.

Number of Shares
21,161
Previous 16,764 26.23%
Holding current value
$153,628
Previous $345,000 19.71%
% of portfolio
0.16%
Previous 0.14%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.57 - $23.23 $81,652 - $102,142
4,397 Added 26.23%
21,161 $413,000
Q2 2024

Aug 14, 2024

BUY
$17.53 - $22.98 $293,872 - $385,236
16,764 New
16,764 $345,000
Q2 2023

Aug 14, 2023

BUY
$9.62 - $13.99 $226,502 - $329,394
23,545 Added 80.52%
52,787 $558,000
Q1 2023

May 15, 2023

SELL
$10.71 - $14.6 $1.44 Million - $1.97 Million
-134,871 Reduced 82.18%
29,242 $357,000
Q4 2022

Feb 14, 2023

SELL
$11.23 - $16.9 $381,404 - $573,974
-33,963 Reduced 17.15%
164,113 $2.04 Million
Q3 2022

Nov 14, 2022

SELL
$12.01 - $19.45 $238,026 - $385,479
-19,819 Reduced 9.1%
198,076 $2.71 Million
Q2 2022

Aug 15, 2022

BUY
$10.71 - $18.33 $750,364 - $1.28 Million
70,062 Added 47.39%
217,895 $3.99 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $774,052 - $1.12 Million
65,709 Added 80.01%
147,833 $2.38 Million
Q4 2021

Feb 14, 2022

BUY
$12.22 - $19.57 $137,303 - $219,888
11,236 Added 15.85%
82,124 $1.15 Million
Q3 2021

Nov 15, 2021

BUY
$15.42 - $21.72 $500,533 - $705,031
32,460 Added 84.47%
70,888 $1.33 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $171,303 - $245,494
8,216 Added 27.19%
38,428 $801,000
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $136,224 - $215,426
5,504 Added 22.28%
30,212 $854,000
Q4 2020

Feb 16, 2021

SELL
$29.0 - $41.62 $3,625 - $5,202
-125 Reduced 0.5%
24,708 $807,000
Q3 2020

Nov 16, 2020

SELL
$16.3 - $30.64 $80,000 - $150,381
-4,908 Reduced 16.5%
24,833 $761,000
Q2 2020

Aug 14, 2020

BUY
$7.95 - $18.81 $236,440 - $559,428
29,741 New
29,741 $485,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $486M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.